Prevalensi Multidrug-Resistant Klebsiella pneumonia dan Evaluasi Kesesuaian Antibiotik Empiris Berdasarkan Nilai Prediksi Farmakokinetik Terhadap Outcome Klinis di RSUP Dr Soeradji Tirtonegoro Klaten

https://doi.org/10.22146/farmaseutik.v16i1.47914

Rizqi Nurul Khasanah(1), Ika Puspitasari(2*), Titik Nuryastuti(3), Nunung Yuniarti(4)

(1) Magister Farmasi Klinik, Fakultas Farmasi, UGM
(2) Faculty of Pharmacy, Universitas Gadjah Mada
(3) Departemen Mikrobiologi, FKKMK, UGM
(4) Departemen Farmakologi dan Farmasi Klinik, Fakultas Farmasi, UGM
(*) Corresponding Author

Abstract


Klebsiella pneumonia is a multidrug resistant (MDR) pathogen that affects morbidity and mortality. MDR K. pneumonia is the bacterium K. pneumonia which has experienced resistance to at least one antibiotic from 3 or more antibiotic groups. The purpose of this study was to see the percentage prevalence of MDR K. pneumonia events and to see profiles of antibiotic sensitivity and predictions of antibiotic pharmacokinetic parameters in hospitalized patients at RSUP dr. Soeradji Tirtonegoro Klaten from 2017 to 2018. This study was an observational study with a cross sectional method and retrospective data collection. Data collected included the number of inpatients who experienced MDR K. pneumonia and the factors that influence the occurrence of antibiotic resistance. The prevalence of MDR K. pneumonia and antibiotic sensitivity evaluation were analyzed descriptively. Prediction of antibiotic pharmacokinetics in patients with MDR K. pneumonia associated with patient clinical outcomes was analyzed in Chi-square. Patients infected with Klebsiella pneumonia as many as 338 patients found 67 patients with MDR K. pneumonia who met the inclusion criteria in hospitalized patients at RSUP dr. Soeradji Tirtonegoro Klaten. The prevalence of MDR K. pneumonia in 2017-2018 is 30.17%. The results of the analysis show that there is a relationship between empirical antibiotic suitability based on pharmacokinetic predictiion value to clinical outcomes with a probability value of P = 0.024 (P <0.05).


Keywords


Resistensi Antibiotik; Antibiotik; MDR Klebsiella pneumonia

Full Text:

PDF


References

Apondi, O.E., Oduor, O.C., Gye, B.K., dan Kipkoech, M.K., 2016. High Prevalence of Multi-Drug Resistant Klebsiella Pneumoniae in a Tertiary Hospitl in Western Kenya. African Journal of Infectious Diseases, 10: 89–95. Dahlan, M. Sopiyudin, 2012. Analisis Survival : Dasar-Dasar Teori Dan Aplikasi Dengan Program SPSS, 11. Epidemiologi Indonesia, Jakarta. Deshpande, J.D. dan Joshi, M., 2011. Antimicrobial Resistance: The Global Public Health Challenge. International Journal of Students’ Research, 1: 41–44. Estiningsih, D., Puspitasari, I., dan Nuryastuti, T., 2016. Identifikasi infeksi Multidrug-Resistant Organisms (MDRO) pada pasien yang dirawat di bangsal Neonatal Intensive Care Unit (PICU) RSUP Dr. Soeradji Tirtonegoro Klaten. Jurnal Manajemen dan Pelayanan Farmasi, 6: 6. Febria, Nugroho Kusuma Dewi, 2017. Evaluasi Penggunaan Antibiotik Empiris dan Definitif pada Pasien Health-Care Associated Pneumonia (HCAP) Rawat Inap di RSUP Dr. Sardjito Yogyakarta. Fakultas Farmasi UGM Yogyakarta, . Gorrie, C.L., Mirceta, M., Wick, R.R., Judd, L.M., Wyres, K.L., Thomson, N.R., dkk., 2018. Antimicrobial-Resistant Klebsiella pneumoniae Carriage and Infection in Specialized Geriatric Care Wards Linked to Acquisition in the Referring Hospital. Clinical Infectious Diseases, 67: 161–170. Hakim, L., 2012. Farmakokinetik Klinik : Konsep Untuk Rasionalisasi Regimen Dosis, Therapeutic Drug Monitoring, Konseling Pasien dan Pengembangan Obat. PT. Bursa Ilmu, Yogyakarta. Malekolkottab, M., Shojaei, L., Khalili, H., dan Doomanlou, M., 2017. Clinical response and outcome in patients with multidrug resistant gram-negative infections. Journal of Research in Pharmacy Practice, 6: 44. Venkatachalam, I., Yang, H.L., Fisher, D., Lye, D.C., Lin, L.M., Tambyah, P., dkk., 2014. Multidrug-Resistant Gram-Negative Bloodstream Infections among Residents of Long-Term Care Facilities. Infection Control & Hospital Epidemiology, 35: 519–526. WHO, 2014. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. The Review on Antimicrobial Resistance Chaired by Jim O’Neill December 2014. World Health Organization. WHO, 2017. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2016-2017. World Health Organization.



DOI: https://doi.org/10.22146/farmaseutik.v16i1.47914

Article Metrics

Abstract views : 62 | views : 60

Refbacks

  • There are currently no refbacks.


Majalah Farmaseutik Indexed by:

   
Lisensi Creative Commons
    web
analytics
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.